214 related articles for article (PubMed ID: 3339135)
1. Reduction of experimental canine myocardial reperfusion injury by a monoclonal antibody (anti-Mo1, anti-CD11b) that inhibits leukocyte adhesion.
Simpson PJ; Todd RF; Fantone JC; Mickelson JK; Griffin JD; Lucchesi BR
J Clin Invest; 1988 Feb; 81(2):624-9. PubMed ID: 3339135
[TBL] [Abstract][Full Text] [Related]
2. Sustained limitation of myocardial reperfusion injury by a monoclonal antibody that alters leukocyte function.
Simpson PJ; Todd RF; Mickelson JK; Fantone JC; Gallagher KP; Lee KA; Tamura Y; Cronin M; Lucchesi BR
Circulation; 1990 Jan; 81(1):226-37. PubMed ID: 2153476
[TBL] [Abstract][Full Text] [Related]
3. Effect of anti-CD18 antibody on myocardial neutrophil accumulation and infarct size after ischemia and reperfusion in dogs.
Tanaka M; Brooks SE; Richard VJ; FitzHarris GP; Stoler RC; Jennings RB; Arfors KE; Reimer KA
Circulation; 1993 Feb; 87(2):526-35. PubMed ID: 8093866
[TBL] [Abstract][Full Text] [Related]
4. F(ab')2 fragments of anti-Mo1 (904) monoclonal antibodies do not prevent myocardial stunning.
Schott RJ; Nao BS; McClanahan TB; Simpson PJ; Stirling MC; Todd RF; Gallagher KP
Circ Res; 1989 Oct; 65(4):1112-24. PubMed ID: 2551527
[TBL] [Abstract][Full Text] [Related]
5. A chimeric IgG4 monoclonal antibody directed against CD18 reduces infarct size in a primate model of myocardial ischemia and reperfusion.
Aversano T; Zhou W; Nedelman M; Nakada M; Weisman H
J Am Coll Cardiol; 1995 Mar; 25(3):781-8. PubMed ID: 7860929
[TBL] [Abstract][Full Text] [Related]
6. Reduction of experimental canine myocardial infarct size with prostaglandin E1: inhibition of neutrophil migration and activation.
Simpson PJ; Mickelson J; Fantone JC; Gallagher KP; Lucchesi BR
J Pharmacol Exp Ther; 1988 Feb; 244(2):619-24. PubMed ID: 2831348
[TBL] [Abstract][Full Text] [Related]
7. Identification of a time window for therapy to reduce experimental canine myocardial injury: suppression of neutrophil activation during 72 hours of reperfusion.
Simpson PJ; Fantone JC; Mickelson JK; Gallagher KP; Lucchesi BR
Circ Res; 1988 Dec; 63(6):1070-9. PubMed ID: 2461814
[TBL] [Abstract][Full Text] [Related]
8. An anti-CD18 antibody limits infarct size and preserves left ventricular function in dogs with ischemia and 48-hour reperfusion.
Arai M; Lefer DJ; So T; DiPaula A; Aversano T; Becker LC
J Am Coll Cardiol; 1996 Apr; 27(5):1278-85. PubMed ID: 8609356
[TBL] [Abstract][Full Text] [Related]
9. Factors modifying protective effect of anti-CD18 antibodies on myocardial reperfusion injury in dogs.
Perez RG; Arai M; Richardson C; DiPaula A; Siu C; Matsumoto N; Hildreth JE; Mariscalco MM; Smith CW; Becker LC
Am J Physiol; 1996 Jan; 270(1 Pt 2):H53-64. PubMed ID: 8769734
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of Platelet GPVI Protects Against Myocardial Ischemia-Reperfusion Injury.
Pachel C; Mathes D; Arias-Loza AP; Heitzmann W; Nordbeck P; Deppermann C; Lorenz V; Hofmann U; Nieswandt B; Frantz S
Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):629-35. PubMed ID: 26916731
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal antibody to ICAM-1 preserves postischemic blood flow and reduces infarct size after ischemia-reperfusion in rabbit.
Zhao ZQ; Lefer DJ; Sato H; Hart KK; Jefforda PR; Vinten-Johansen J
J Leukoc Biol; 1997 Sep; 62(3):292-300. PubMed ID: 9307067
[TBL] [Abstract][Full Text] [Related]
12. Protection of ischemic/reperfused canine myocardium by CL18/6, a monoclonal antibody to adhesion molecule ICAM-1.
Hartman JC; Anderson DC; Wiltse AL; Lane CL; Rosenbloom CL; Manning AM; Humphrey WR; Wall TM; Shebuski RJ
Cardiovasc Res; 1995 Jul; 30(1):47-54. PubMed ID: 7553723
[TBL] [Abstract][Full Text] [Related]
13. Dynamic progression of contractile and endothelial dysfunction and infarct extension in the late phase of reperfusion.
Zhao ZQ; Nakamura M; Wang NP; Velez DA; Hewan-Lowe KO; Guyton RA; Vinten-Johansen J
J Surg Res; 2000 Dec; 94(2):133-44. PubMed ID: 11104653
[TBL] [Abstract][Full Text] [Related]
14. The role of serotonin (5HT2) receptor blockade in myocardial reperfusion injury: effects of LY53857 in a canine model of myocardial infarction.
Simpson PJ; Schelm JA; Jakubowski JA; Smallwood JK
J Pharmacol Exp Ther; 1991 Sep; 258(3):979-85. PubMed ID: 1653847
[TBL] [Abstract][Full Text] [Related]
15. Effects of a monoclonal antibody directed against P-selectin after myocardial ischemia and reperfusion.
Lefer DJ; Flynn DM; Buda AJ
Am J Physiol; 1996 Jan; 270(1 Pt 2):H88-98. PubMed ID: 8769738
[TBL] [Abstract][Full Text] [Related]
16. Effect of duration of ischaemia on reduction of myocardial infarct size by inhibition of neutrophil accumulation using an anti-CD18 monoclonal antibody.
Williams FM; Kus M; Tanda K; Williams TJ
Br J Pharmacol; 1994 Apr; 111(4):1123-8. PubMed ID: 7913371
[TBL] [Abstract][Full Text] [Related]
17. Adenosine attenuates reperfusion-induced apoptotic cell death by modulating expression of Bcl-2 and Bax proteins.
Zhao ZQ; Budde JM; Morris C; Wang NP; Velez DA; Muraki S; Guyton RA; Vinten-Johansen J
J Mol Cell Cardiol; 2001 Jan; 33(1):57-68. PubMed ID: 11133223
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic defibrination with ancrod does not protect canine myocardium from reperfusion injury.
Simpson PJ; Schelm JA; Smith GF
J Pharmacol Exp Ther; 1991 Feb; 256(2):780-6. PubMed ID: 1704437
[TBL] [Abstract][Full Text] [Related]
19. Myocardial ischemia/reperfusion injury is mediated by leukocytic toll-like receptor-2 and reduced by systemic administration of a novel anti-toll-like receptor-2 antibody.
Arslan F; Smeets MB; O'Neill LA; Keogh B; McGuirk P; Timmers L; Tersteeg C; Hoefer IE; Doevendans PA; Pasterkamp G; de Kleijn DP
Circulation; 2010 Jan; 121(1):80-90. PubMed ID: 20026776
[TBL] [Abstract][Full Text] [Related]
20. Reduction of myocardial ischemia-reperfusion injury by KT-362, a new intracellular calcium antagonist in anesthetized dogs.
Pelc LR; Farber NE; Warltier DC; Gross GJ
J Cardiovasc Pharmacol; 1989 Apr; 13(4):586-93. PubMed ID: 2470996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
